NCT00642915View on ClinicalTrials.gov

Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

July 31, 2004

Conditions
Diabetes Mellitus
Interventions
DRUG

Lantus, Amaryl

Trial Locations (1)

Unknown

Sanofi-Aventis, São Paulo

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00642915 - Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil) | Biotech Hunter | Biotech Hunter